Raj Iyer

Raj Iyer is an accomplished leader in the biotechnology and pharmaceutical industries, currently serving as Founder and CEO of BioKriya since October 2022, providing market insights and execution strategies for capital raising and M&A. Iyer is also a member of the Board of Directors at Gliding Eagle Inc, which focuses on connecting manufacturers and consumers through a digital platform. Previously, Iyer held significant roles at Porton Pharma Solutions as Chief Business Officer and at Opal Oncology as a Board Advisor. Additional experience includes serving as President at Arch and as Director of Business Development at Solvay Chemicals. Iyer's early career saw contributions as a Senior Scientist at Mylan Specialty and as a Scientist at Pfizer. Educational qualifications include a Post-Doctoral Research Fellowship at Yale School of Medicine, a Ph.D. in Analytical Biochemistry from The George Washington University, and a Master's degree from the Institute of Chemical Technology.